262 related articles for article (PubMed ID: 20106868)
41. WT1, WTX and CTNNB1 mutation analysis in 43 patients with sporadic Wilms' tumor.
Cardoso LC; De Souza KR; De O Reis AH; Andrade RC; Britto AC; De Lima MA; Dos Santos AC; De Faria PS; Ferman S; Seuánez HN; Vargas FR
Oncol Rep; 2013 Jan; 29(1):315-20. PubMed ID: 23117548
[TBL] [Abstract][Full Text] [Related]
42. Convergent evolution of 11p allelic loss in multifocal Wilms tumors arising in WT1 mutation carriers.
Valind A; Wessman S; Pal N; Karlsson J; Jonson T; Sandstedt B; Gisselsson D
Pediatr Blood Cancer; 2018 Nov; 65(11):e27301. PubMed ID: 29968962
[TBL] [Abstract][Full Text] [Related]
43. The murine Pou6f2 gene is temporally and spatially regulated during kidney embryogenesis and its human homolog is overexpressed in a subset of Wilms tumors.
Di Renzo F; Doneda L; Menegola E; Sardella M; De Vecchi G; Collini P; Spreafico F; Fossati-Bellani F; Giavini E; Radice P; Perotti D
J Pediatr Hematol Oncol; 2006 Dec; 28(12):791-7. PubMed ID: 17164647
[TBL] [Abstract][Full Text] [Related]
44. PAX3 is expressed in the stromal compartment of the developing kidney and in Wilms tumors with myogenic phenotype.
Hueber PA; Fukuzawa R; Elkares R; Chu L; Blumentkrantz M; He SJ; Anaka MR; Reeve AE; Eccles M; Jabado N; Iglesias DM; Goodyer PR
Pediatr Dev Pathol; 2009; 12(5):347-54. PubMed ID: 18666806
[TBL] [Abstract][Full Text] [Related]
45. Clinically relevant subsets identified by gene expression patterns support a revised ontogenic model of Wilms tumor: a Children's Oncology Group Study.
Gadd S; Huff V; Huang CC; Ruteshouser EC; Dome JS; Grundy PE; Breslow N; Jennings L; Green DM; Beckwith JB; Perlman EJ
Neoplasia; 2012 Aug; 14(8):742-56. PubMed ID: 22952427
[TBL] [Abstract][Full Text] [Related]
46. WTX inactivation is a frequent, but late event in Wilms tumors without apparent clinical impact.
Wegert J; Wittmann S; Leuschner I; Geissinger E; Graf N; Gessler M
Genes Chromosomes Cancer; 2009 Dec; 48(12):1102-11. PubMed ID: 19760609
[TBL] [Abstract][Full Text] [Related]
47. Nephron Progenitor But Not Stromal Progenitor Cells Give Rise to Wilms Tumors in Mouse Models with β-Catenin Activation or Wt1 Ablation and Igf2 Upregulation.
Huang L; Mokkapati S; Hu Q; Ruteshouser EC; Hicks MJ; Huff V
Neoplasia; 2016 Feb; 18(2):71-81. PubMed ID: 26936393
[TBL] [Abstract][Full Text] [Related]
48. Wilms tumor genetics: mutations in WT1, WTX, and CTNNB1 account for only about one-third of tumors.
Ruteshouser EC; Robinson SM; Huff V
Genes Chromosomes Cancer; 2008 Jun; 47(6):461-70. PubMed ID: 18311776
[TBL] [Abstract][Full Text] [Related]
49. Frequent association of beta-catenin and WT1 mutations in Wilms tumors.
Maiti S; Alam R; Amos CI; Huff V
Cancer Res; 2000 Nov; 60(22):6288-92. PubMed ID: 11103785
[TBL] [Abstract][Full Text] [Related]
50. Resistance or sensitivity of Wilms' tumor to anti-FZD7 antibody highlights the Wnt pathway as a possible therapeutic target.
Pode-Shakked N; Harari-Steinberg O; Haberman-Ziv Y; Rom-Gross E; Bahar S; Omer D; Metsuyanim S; Buzhor E; Jacob-Hirsch J; Goldstein RS; Mark-Danieli M; Dekel B
Oncogene; 2011 Apr; 30(14):1664-80. PubMed ID: 21472018
[TBL] [Abstract][Full Text] [Related]
51. WT1 in disease: shifting the epithelial-mesenchymal balance.
Miller-Hodges E; Hohenstein P
J Pathol; 2012 Jan; 226(2):229-40. PubMed ID: 21959952
[TBL] [Abstract][Full Text] [Related]
52. Establishment of a Conditionally Immortalized Wilms Tumor Cell Line with a Homozygous WT1 Deletion within a Heterozygous 11p13 Deletion and UPD Limited to 11p15.
Brandt A; Löhers K; Beier M; Leube B; de Torres C; Mora J; Arora P; Jat PS; Royer-Pokora B
PLoS One; 2016; 11(5):e0155561. PubMed ID: 27213811
[TBL] [Abstract][Full Text] [Related]
53. Characterization of primary Wilms tumor cultures as an in vitro model.
Wegert J; Bausenwein S; Roth S; Graf N; Geissinger E; Gessler M
Genes Chromosomes Cancer; 2012 Jan; 51(1):92-104. PubMed ID: 22034155
[TBL] [Abstract][Full Text] [Related]
54. Significant reduction of WT1 gene expression, possibly due to epigenetic alteration in Wilms' tumor.
Satoh Y; Nakagawachi T; Nakadate H; Kaneko Y; Masaki Z; Mukai T; Soejima H
J Biochem; 2003 Mar; 133(3):303-8. PubMed ID: 12761165
[TBL] [Abstract][Full Text] [Related]
55. Derivation and characterization of human fetal MSCs: an alternative cell source for large-scale production of cardioprotective microparticles.
Lai RC; Arslan F; Tan SS; Tan B; Choo A; Lee MM; Chen TS; Teh BJ; Eng JK; Sidik H; Tanavde V; Hwang WS; Lee CN; El Oakley RM; Pasterkamp G; de Kleijn DP; Tan KH; Lim SK
J Mol Cell Cardiol; 2010 Jun; 48(6):1215-24. PubMed ID: 20064522
[TBL] [Abstract][Full Text] [Related]
56. Bilateral Wilms tumor and early presentation in pediatric patients is associated with the truncation of the Wilms tumor 1 protein.
Hu M; Fletcher J; McCahon E; Catchpoole D; Zhang GY; Wang YM; Algar EM; Alexander SI
J Pediatr; 2013 Jul; 163(1):224-9. PubMed ID: 23403252
[TBL] [Abstract][Full Text] [Related]
57. Loss of heterozygosity mapping in Wilms tumor indicates the involvement of three distinct regions and a limited role for nondisjunction or mitotic recombination.
Coppes MJ; Bonetta L; Huang A; Hoban P; Chilton-MacNeill S; Campbell CE; Weksberg R; Yeger H; Reeve AE; Williams BR
Genes Chromosomes Cancer; 1992 Nov; 5(4):326-34. PubMed ID: 1283321
[TBL] [Abstract][Full Text] [Related]
58. Comparative Gene Expression Profiling of Primary and Metastatic Renal Cell Carcinoma Stem Cell-Like Cancer Cells.
Khan MI; Czarnecka AM; Lewicki S; Helbrecht I; Brodaczewska K; Koch I; Zdanowski R; Król M; Szczylik C
PLoS One; 2016; 11(11):e0165718. PubMed ID: 27812180
[TBL] [Abstract][Full Text] [Related]
59. WNT/beta-catenin pathway activation in Wilms tumors: a unifying mechanism with multiple entries?
Corbin M; de Reyniès A; Rickman DS; Berrebi D; Boccon-Gibod L; Cohen-Gogo S; Fabre M; Jaubert F; Faussillon M; Yilmaz F; Sarnacki S; Landman-Parker J; Patte C; Schleiermacher G; Antignac C; Jeanpierre C
Genes Chromosomes Cancer; 2009 Sep; 48(9):816-27. PubMed ID: 19530245
[TBL] [Abstract][Full Text] [Related]
60. Correlation of germ-line mutations and two-hit inactivation of the WT1 gene with Wilms tumors of stromal-predominant histology.
Schumacher V; Schneider S; Figge A; Wildhardt G; Harms D; Schmidt D; Weirich A; Ludwig R; Royer-Pokora B
Proc Natl Acad Sci U S A; 1997 Apr; 94(8):3972-7. PubMed ID: 9108089
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]